Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Classifica tra le azioni #2521
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Prezzo delle azioni
$100.24
Capitalizzazione di mercato
$7.51B
Variazione (1 giorno)
-1.84%
Variazione (1 anno)
48.99%
Paese
CH
Scambia Bachem Holding AG (BANB)

Categoria

Healthcare
Storico del prezzo dell'azione per Bachem Holding AG (BANB)
Prezzo di chiusura piΓΉ alto: $105.12 il 2026-10-01

Prezzo di chiusura piΓΉ basso: $13.47 il 2001-03-01
Storico del prezzo dell'azione di Bachem Holding AG dal 2001 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$523.31 22.71%
US
$237.47 784.43%
US
$137.83 -3.78%
AU
$874.99 7.47%
NL
$287.83 1.13%
BE